Details
 

February 25, 2023
7:00AM - 4:00PM EST

Physician Program

OOS Annual Meeting

View Physician Agenda > 

Register to Attend >


LEARNING OBJECTIVES:

  • Discuss the prevalence and impact of retina disease, glaucoma, and other external diseases;
  • Review current literature and discuss new and emerging data aimed at improving the management of patients;
  • Incorporate best available evidence and recent clinical research to improve patient assessment and treatment approaches; and,
  • Apply quality and risk management strategies to address critical business issues in the ophthalmology practice.

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ohio State Medical Association (OSMA) and the Ohio Ophthalmological Society. The OSMA is accredited by the ACCME to provide continuing medical education for physicians.

The OSMA designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


ABO MOC RECOGNITON
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit towards the Lifelong Learning requirement for the American Board of Ophthalmology’s Continuing Certification program. The OSMA, as the CME provider, will submit learner completion information to the ACCME for the purpose of granting credit.



SUBSTITUTIONS/CANCELLATIONS
Cancellations made on or before 4 pm on Thursday, Feb. 16 will receive a full refund. If made Friday, Feb. 17 or after, you will receive a refund less a $100 processing fee, or you can have the full registration applied to your 2024 registration. There will be no refunds for anyone who does not cancel in advance and/or doesn't show the day of the meeting. If the OOS cancels for any reason, 100% registration refunds will be made. Substitutions can be made at no charge.


EVENT EXHIBITORS:

Alcon Vision
Alexion AstraZeneca
Allergan, an AbbVie Company
Apellis Pharmaceuticals
Association of Technical Personnel
Bausch + Lomb
BioTissue Ocular
CVP Physicians & EyeCare Partners
Dompe Pharmaceuticals
Eversight
Genentech
Glaukos
Heidelberg Engineering
Horizon Therapeutics
Icare USA, Inc
Immunocore
Iridex
Johnson and Johnson Vision
Lions Eye Bank of West Central Ohio
Lumenis
Mallinckrodt Pharmaceuticals
Modernizing Medicine
New World Medical
Nextech
Notal Vision
Ocular Therapeutix
OMIC
Optos Inc.
Premier Ophthalmic Services
Rayner Surgical
Regeneron Pharmaceuticals Inc.
RxSight, Inc.
Sanofi
Scope Eyecare & Healthcare
Topcon Healthcare
Travere Therapeutics
Westmoreland Pharmacy
ZEISS

 

Printer-Friendly Version


Add to Calendar aCLuDhaqizCaPxAftmqF167204 02/25/2023 07:00 AM 02/25/2023 04:00 PM false America/New York Physician Program View Physician Agenda >  Register to Attend > LEARNING OBJECTIVES: Discuss the prevalence and impact of retina disease, glaucoma, and other external diseases; Review current literature and discuss new and emerging data aimed at improving the management of patients; Incorporate best available evidence and recent clinical research to improve patient assessment and treatment approaches; and, Apply quality and risk management strategies to address critical business issues in the ophthalmology practice. Continuing Medical EducationThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ohio State Medical Association (OSMA) and the Ohio Ophthalmological Society. The OSMA is accredited by the ACCME to provide continuing medical education for physicians. The OSMA designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  ABO MOC RECOGNITONSuccessful completion of this CME activity, which includes participation in the evaluation component, earns credit towards the Lifelong Learning requirement for the American Board of Ophthalmology’s Continuing Certification program. The OSMA, as the CME provider, will submit learner completion information to the ACCME for the purpose of granting credit. SUBSTITUTIONS/CANCELLATIONSCancellations made on or before 4 pm on Thursday, Feb. 16 will receive a full refund. If made Friday, Feb. 17 or after, you will receive a refund less a $100 processing fee, or you can have the full registration applied to your 2024 registration. There will be no refunds for anyone who does not cancel in advance and/or doesn't show the day of the meeting. If the OOS cancels for any reason, 100% registration refunds will be made. Substitutions can be made at no charge. EVENT EXHIBITORS: Alcon VisionAlexion AstraZenecaAllergan, an AbbVie CompanyApellis PharmaceuticalsAssociation of Technical PersonnelBausch + LombBioTissue OcularCVP Physicians & EyeCare PartnersDompe PharmaceuticalsEversightGenentechGlaukosHeidelberg EngineeringHorizon TherapeuticsIcare USA, IncImmunocoreIridexJohnson and Johnson VisionLions Eye Bank of West Central OhioLumenisMallinckrodt PharmaceuticalsModernizing MedicineNew World MedicalNextechNotal VisionOcular TherapeutixOMICOptos Inc.Premier Ophthalmic ServicesRayner SurgicalRegeneron Pharmaceuticals Inc.RxSight, Inc.SanofiScope Eyecare & HealthcareTopcon HealthcareTravere TherapeuticsWestmoreland PharmacyZEISS   ----